Division of Cardiovascular Medicine

February 1, 2024

A biomarker for early Type 2 diabetes

Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

By Bill Snyder
December 19, 2023

Three from VUMC elected to ASCI

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

By Bill Snyder
Daniel Muñoz, MD, MPA
November 30, 2023

Daniel Muñoz and Francis Miller named interim directors of the Division of Cardiovascular Medicine

Daniel Muñoz, MD, MPA, associate professor of Medicine, and Francis Miller, MD, professor of Medicine, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.

By Matt Batcheldor
November 17, 2023

Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute

Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute

By John Howser
November 13, 2023

Most can lower blood pressure by reducing salt, even those on BP drugs: study

New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake.

By Bill Snyder
October 27, 2023

Grant bolsters research to address rising maternal mortality rates

Study seeks to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

By Matt Batcheldor
October 5, 2023

Study finds no difference in heart transplant outcomes using organs donated after circulatory death and after brain death

A Vanderbilt study found no difference in one-year survival and other outcomes among heart transplant patients who received their new organs from from donation after circulatory death and donation after brain death.
By Matt Batcheldor
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.
By Paul Govern
April 6, 2023

COVID-19’s lingering impact on health

A decline in cardiovascular fitness — measured by activity trackers in the All of Us research program — persisted among some groups even after COVID-related restrictions were relaxed, exacerbating health disparities.
By Bill Snyder
March 6, 2023

Cell-free hemoglobin in pulmonary hypertension

Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.
By Leigh MacMillan
February 23, 2023

2022 another strong year for Vanderbilt Transplant Center

By Matt Batcheldor
February 23, 2023

Study sheds new light on hormone therapy as menopause treatment

Vanderbilt research shows that hormone replacement therapy can be safely administered depending on the method used and the patient’s age, time since menopause, and risk of cardiovascular disease.
By Matt Batcheldor
February 7, 2023

A new view of a cholesterol carrier

Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.
By Kelsey Pinckard 
1 2 3 4 … 11